Literature DB >> 8415619

Loss of resistance to dietary cholesterol in the rat after hypophysectomy: importance of the presence of growth hormone for hepatic low density lipoprotein-receptor expression.

M Rudling1, B Angelin.   

Abstract

This investigation was undertaken to determine the role of pituitary function and, in particular, the possible influence of growth hormone (GH) on hepatic low density lipoprotein (LDL)-receptor expression in response to dietary cholesterol. Feeding normal rats with 2% cholesterol for 5 or 6 days did not alter LDL-receptor numbers, LDL-receptor mRNA levels, or plasma cholesterol, although hepatic cholesterol increased 5-fold. When hypophysectomized rats received the same diet, the LDL-receptor number and its mRNA levels were reduced by 75%, plasma cholesterol increased 6-fold, and hepatic cholesterol increased 12-fold. Stepwise hormonal substitution of cholesterol-fed, hypophysectomized rats revealed that substitution with GH was important to restore hepatic LDL-receptor number and mRNA levels. The presence of GH was also important to reduce the hypercholesterolemia in cholesterol-fed hypophysectomized rats. We conclude that the presence of GH is important for hepatic LDL-receptor expression, both at the protein and the mRNA level. The resistance to suppression of rat hepatic LDL receptors by dietary cholesterol depends, at least in part, on the presence of GH.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415619      PMCID: PMC47458          DOI: 10.1073/pnas.90.19.8851

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Pituitary growth hormone essential for regulation of serum cholesterol.

Authors:  M Friedman; S O Byers; S R Elek
Journal:  Nature       Date:  1970-01-31       Impact factor: 49.962

2.  Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study.

Authors:  G Heiss; I Tamir; C E Davis; H A Tyroler; B M Rifkand; G Schonfeld; D Jacobs; I D Frantz
Journal:  Circulation       Date:  1980-02       Impact factor: 29.690

3.  Evidence for an endogenous ultradian rhythm governing growth hormone secretion in the rat.

Authors:  G S Tannenbaum; J B Martin
Journal:  Endocrinology       Date:  1976-03       Impact factor: 4.736

4.  Lipoproteins, cardiovascular disease, and death. The Framingham study.

Authors:  T Gordon; W B Kannel; W P Castelli; T R Dawber
Journal:  Arch Intern Med       Date:  1981-08

5.  Impaired growth hormone secretion in the adult population: relation to age and adiposity.

Authors:  D Rudman; M H Kutner; C M Rogers; M F Lubin; G A Fleming; R P Bain
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

6.  Sterol metabolism studies in the rat. Effects of primary bile acids (sodium taurochenodeoxycholate and sodium taurocholate) on sterol metabolism.

Authors:  B I Cohen; R F Raicht; E H Mosbach
Journal:  J Lipid Res       Date:  1977-03       Impact factor: 5.922

7.  Growth hormone in the regulation of hyperlipidemia.

Authors:  P R Blackett; P K Weech; W J McConathy; J D Fesmire
Journal:  Metabolism       Date:  1982-02       Impact factor: 8.694

8.  Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits.

Authors:  P T Kovanen; M S Brown; S K Basu; D W Bilheimer; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

9.  Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors.

Authors:  D Y Hui; T L Innerarity; R W Mahley
Journal:  J Biol Chem       Date:  1981-06-10       Impact factor: 5.157

10.  Stimulation of rat hepatic low density lipoprotein receptors by glucagon. Evidence of a novel regulatory mechanism in vivo.

Authors:  M Rudling; B Angelin
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

View more
  6 in total

1.  Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial.

Authors:  Miriam A Bredella; Eleanor Lin; Danielle J Brick; Anu V Gerweck; Lindsey M Harrington; Martin Torriani; Bijoy J Thomas; David A Schoenfeld; Anne Breggia; Clifford J Rosen; Linda C Hemphill; Zida Wu; Nader Rifai; Andrea L Utz; Karen K Miller
Journal:  Eur J Endocrinol       Date:  2012-01-24       Impact factor: 6.664

2.  Effects of GH on body composition and cardiovascular risk markers in young men with abdominal obesity.

Authors:  Miriam A Bredella; Anu V Gerweck; Eleanor Lin; Melissa G Landa; Martin Torriani; David A Schoenfeld; Linda C Hemphill; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2013-07-03       Impact factor: 5.958

3.  Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat.

Authors:  M Rudling; P Parini; B Angelin
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

Review 4.  Effects of adiposity on plasma lipid response to reductions in dietary saturated fatty acids and cholesterol.

Authors:  Michael R Flock; Michael H Green; Penny M Kris-Etherton
Journal:  Adv Nutr       Date:  2011-04-30       Impact factor: 8.701

5.  Regulation of rat hepatic low density lipoprotein receptors. In vivo stimulation by growth hormone is not mediated by insulin-like growth factor I.

Authors:  M Rudling; H Olivecrona; G Eggertsen; B Angelin
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

6.  Endotoxin suppresses rat hepatic low-density lipoprotein receptor expression.

Authors:  W Liao; M Rudling; B Angelin
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.